Literature DB >> 10064151

Effects of corticosteroid, contrast medium and ATP on focal microcirculatory disorders of the cochlea.

M Nagura1, S Iwasaki, R Wu, K Mizuta, K Umemura, T Hoshino.   

Abstract

We evaluated the ability of various drugs to prevent the decrease in focal cochlear blood flow induced by photochemical reaction and investigated the mechanisms underlying this decrease. By means of a photochemical reaction, which produces reactive oxygen species, focal lesions measuring about 1 mm in diameter were induced in the lateral wall of the guinea pig cochlea. The protective effects of hydrocortisone, amidotrizoate and ATP on cochlear blood flow and cochlear vascular conductance changes were evaluated by using a non-contact laser flowmeter. Cochlear blood flow and cochlear vascular conductance were decreased to 65.1+/-4.9% (mean +/- S.E.M.) and 57.0+/-3.7% (mean +/- S.E.M.) of the initial level 30 min after the start of the photochemical reaction, respectively. Hydrocortisone significantly prevented the decline in the cochlear blood flow and cochlear vascular conductance and reduced the area of stria vascularis degeneration in a dose-dependent manner. Neither amidotrizoate nor ATP significantly prevented the decrease in cochlear blood flow or cochlear vascular conductance. Hydrocortisone was more effective than vasodilators or other agents which increase cochlear blood flow in preventing the photochemically induced decrease in cochlear blood flow. This might be due to the antioxidative effects of hydrocortisone.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10064151     DOI: 10.1016/s0014-2999(98)00881-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  13 in total

1.  A Polymer-Based Extended Release System for Stable, Long-term Intracochlear Drug Delivery.

Authors:  Erik Pierstorff; Shanshan Chen; Maria Paola Chaparro; John M Cortez; Yen-Jung Chen; Su Young Ryu; Sherry M Tsai; Marc M Baum; Wan Wan Yang; Federico Kalinec; Thomas Smith; Stacey Ludwig; William H Slattery
Journal:  Otol Neurotol       Date:  2018-10       Impact factor: 2.311

2.  The protective effects of intratympanic dexamethasone and vitamin E on cisplatin-induced ototoxicity are demonstrated in rats.

Authors:  Mustafa Paksoy; Emin Ayduran; Arif Sanlı; Mehmet Eken; Sedat Aydın; Zeynep Alev Oktay
Journal:  Med Oncol       Date:  2010-03-19       Impact factor: 3.064

3.  Prevention of cisplatin-induced hearing loss by extended release fluticasone propionate intracochlear implants.

Authors:  Erik Pierstorff; Wan-Wan Yang; Yen-Jung Angel Chen; Shirley Cheung; Federico Kalinec; William H Slattery
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-03-20       Impact factor: 1.675

Review 4.  Intratympanic steroids as primary initial treatment of idiopathic sudden sensorineural hearing loss. The Hospital Universitario Ramón y Cajal experience and review of the literature.

Authors:  Tomás Labatut; María José Daza; Antonio Alonso
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-20       Impact factor: 2.503

5.  Intratympanic dexamethasone on cochlear blood flow in Guinea pigs.

Authors:  Rayleigh Ping-Ying Chiang; Ching-Ying Yeh; Yuh-Chyun Chiang; Kai-Nan Lin
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-04-25

6.  Cisplatin-induced ototoxicity: effect of intratympanic dexamethasone injections.

Authors:  Gerhard W Hill; D Kent Morest; Kourosh Parham
Journal:  Otol Neurotol       Date:  2008-10       Impact factor: 2.311

7.  Long Term Outcomes of Intratympanic Dexamethasone in Intractable Unilateral Meniere's Disease.

Authors:  Pradeep Pradhan; Priti Lal; Kanwar Sen
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-06-24

Review 8.  Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline.

Authors:  David R Freyer; Penelope R Brock; Kay W Chang; L Lee Dupuis; Sidnei Epelman; Kristin Knight; Denise Mills; Robert Phillips; Emma Potter; Demie Risby; Philippa Simpkin; Michael Sullivan; Sandra Cabral; Paula D Robinson; Lillian Sung
Journal:  Lancet Child Adolesc Health       Date:  2019-12-19

9.  Intratympanic dexamethasone injection vs methylprednisolone for the treatment of refractory sudden sensorineural hearing loss.

Authors:  Nezamoddin Berjis; Saeed Soheilipour; Alireza Musavi; Seyed Mostafa Hashemi
Journal:  Adv Biomed Res       Date:  2016-06-20

10.  Intratympanic steroid treatment for idiopathic sudden sensorineural hearing loss after failure of intravenous therapy.

Authors:  Emanuele Ferri; Antonio Frisina; Anna Chiara Fasson; Enrico Armato; Giacomo Spinato; Maurizio Amadori
Journal:  ISRN Otolaryngol       Date:  2012-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.